340B Drug Pricing Program
Complaint and brief: The American Hospital Association (AHA), the Association of American Medical Colleges (AAMC), and America’s Essential Hospitals, along with three hospital plaintiffs, refiled their lawsuit against the HHS to reverse Medicare payment cuts for many hospitals in the 340B Drug…
A recent article in the New York Times, “A Little-Known Windfall for Some Hospitals, Now Facing Big Cuts,” gives a thoroughly inaccurate and misleading view of the 340B Drug Pricing Program.
House Energy and Commerce Committee leaders Aug. 30 sent a letter to the Medicare Payment Advisory Commission asking it to conduct additional research on hospital consolidation and the financial impact it has on Medicare patients and the program.
Legislators sent a letter to the Health Resources and Services Administration urging the agency to implement regulations to better administer the 340B drug savings program.
On July 25, the Centers for Medicare & Medicaid Services (CMS) issued its CY 2019 outpatient prospective payment system/ambulatory surgical center proposed rule. In addition to standard updates, the rule would substantially expand Medicare site-neutral payment policies in several areas and make…
House Energy and Commerce Committee leaders yesterday sent letters to nine contract pharmacies that participate in the 340B drug savings program requesting information about their participation in the program.
The Centers for Medicare & Medicaid Services today proposed to update hospital outpatient prospective payment system rates by 1.25% in calendar year 2019 compared to CY 2018.
Tom Nickels
Executive Vice President
The Government Accountability Office yesterday released a report examining the characteristics of hospitals that participate in the 340B drug savings program and hospitals that do not participate in the program.
The AHA, Association of American Medical Colleges and America’s Essential Hospitals today said they expect to “refile promptly in district court” their lawsuit challenging a nearly 30% Medicare payment reduction for many hospitals in the 340B drug savings program.